Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 16 AL 30

Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms

Sridharan B, Lee MJ.

Curr Mol Med. 2022;22(7):640-656. doi: 10.2174/1566524021666211004104703.

Precision Psychiatry: Machine Learning as a Tool to Find New Pharmacological Targets

Rema J, Novais F, Telles-Correia D.

Curr Top Med Chem. 2022;22(15):1261-1269. doi: 10.2174/1568026621666211004095917.

Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer's Disease

de Sousa NF, Scotti L, de Moura ÉP, Dos Santos Maia M, Rodrigues GCS, de Medeiros HIR, Lopes SM, Scotti MT.

Curr Neuropharmacol. 2022;20(5):857-885. doi: 10.2174/1570159X19666211005145952.

Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms

Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P.

Curr Top Behav Neurosci. 2022;56:287-317. doi: 10.1007/7854_2021_267.

The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil

Gulcan HO, Kosar M.

Curr Top Med Chem. 2022 Mar 4;22(5):395-407. doi: 10.2174/1568026621666211111153626.

Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San

Fu X, Liu Q, Sun X, Chang H, Liu Y, Han J.

J Alzheimers Dis. 2022;85(1):7-19. doi: 10.3233/JAD-210656.

A Comprehensive Review on Medicinal Herbs and Novel Formulations for the Prevention of Alzheimer's Disease

Singh B, Singh H, Singh B, Kumar N, Rajput A, Sidhu D, Kaur A, Arora S, Kaur S.

Curr Drug Deliv. 2022;19(2):212-228. doi: 10.2174/1567201818666211015152733.

A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer's Disease

Kumar M, Bansal N.

Curr Drug Targets. 2022;23(5):486-512. doi: 10.2174/1389450122666211118125233.

A(2A) Adenosine Receptor Antagonists in Neurodegenerative Diseases

Merighi S, Borea PA, Varani K, Vincenzi F, Jacobson KA, Gessi S.

Curr Med Chem. 2022;29(24):4138-4151. doi: 10.2174/0929867328666211129122550.

Amylin Pharmacology in Alzheimer's Disease Pathogenesis and Treatment

Corrigan RR, Piontkivska H, Casadesus G.

Curr Neuropharmacol. 2022;20(10):1894-1907. doi: 10.2174/1570159X19666211201093147.

BACE1: A Key Regulator in Alzheimer's Disease Progression and Current Development of its Inhibitors

Patel S, Bansoad AV, Singh R, Khatik GL.

Curr Neuropharmacol. 2022;20(6):1174-1193. doi: 10.2174/1570159X19666211201094031.

Synthesis and inhibitory activities of inhibitors for the treatment of Alzheimer's disease

Zhou S, Huang G.

Chem Biol Drug Des. 2022 May;99(5):727-735. doi: 10.1111/cbdd.14016. Epub 2022 Feb 10.

Warming needle moxibustion for Alzheimer's disease: A systematic review of randomized controlled trials

Chen X, Liu F, Lin N, Lin Q, Lyu Z, Xiu H, Nie P.

Geriatr Nurs. 2022 Jan-Feb;43:219-226. doi: 10.1016/j.gerinurse.2021.12.004.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias